アジェンダ
1:30 PM — 4:30 PM
Workshop: Dropouts from Randomized Trials in the Regulatory Environment8:45 AM — 9:00 AM
Welcome and Opening Remarks9:00 AM — 10:00 AM
Keynote Address: Future of Clinical Trials (Innovation)11:00 AM — 12:30 PM
Session 1- Biomarkers and Surrogate Endpoints1:30 PM — 3:00 PM
Session 2 - Meta-analysis for Safety Assessment3:30 PM — 5:00 PM
Session 3 - Benefit-Risk Assessment: Foundations and Emerging Frontiers10:30 AM — 12:00 PM
Session 5 – Innovative Trial Design12:00 PM — 1:30 PM
Luncheon and Roundtable Discussions1:30 PM — 3:00 PM
Session 6 – Subgroup Analyses3:30 PM — 5:00 PM
Session 7 – Leadership in a Collaborative Environment5:00 PM — 7:00 PM
Networking Reception and Poster Session8:30 AM — 10:00 AM
Session 8 – Phase 2 Dose-Finding Studies, Part I10:30 AM — 12:00 PM
Session 9 – Phase 2 Dose-Finding Studies, Part II1:00 PM — 2:30 PM
Session 10 – Adaptive Design: New FDA Experiences3:00 PM — 4:30 PM
Session 11 – Statistics Town Hall